GB201914910D0 - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- GB201914910D0 GB201914910D0 GB201914910A GB201914910A GB201914910D0 GB 201914910 D0 GB201914910 D0 GB 201914910D0 GB 201914910 A GB201914910 A GB 201914910A GB 201914910 A GB201914910 A GB 201914910A GB 201914910 D0 GB201914910 D0 GB 201914910D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201914910A GB201914910D0 (en) | 2019-10-15 | 2019-10-15 | Pharmaceutical compounds |
PCT/EP2020/078960 WO2021074251A1 (en) | 2019-10-15 | 2020-10-14 | Pyrrolo[2,3-d]pyrimidine derivatives and their use in the treatment of cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201914910A GB201914910D0 (en) | 2019-10-15 | 2019-10-15 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201914910D0 true GB201914910D0 (en) | 2019-11-27 |
Family
ID=68619675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201914910A Ceased GB201914910D0 (en) | 2019-10-15 | 2019-10-15 | Pharmaceutical compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201914910D0 (en) |
WO (1) | WO2021074251A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117222649A (en) * | 2021-04-30 | 2023-12-12 | 微境生物医药科技(上海)有限公司 | Pyrrolopyrimidine derivatives, process for their preparation and their use |
WO2022228512A1 (en) * | 2021-04-30 | 2022-11-03 | 微境生物医药科技(上海)有限公司 | Pyrrolopyrimidine derivative as wee-1 inhibitor |
CN117751123A (en) * | 2021-08-31 | 2024-03-22 | 微境生物医药科技(上海)有限公司 | 5-fluoro-7H-pyrrolo [2,3-d ] pyrimidines as Wee-1 inhibitors |
TW202345806A (en) | 2022-03-31 | 2023-12-01 | 美商艾伯維有限公司 | Thiazolo[5,4-b]pyridine malt-1 inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009098236A1 (en) * | 2008-02-06 | 2009-08-13 | Novartis Ag | Pyrrolo [2, 3-d] pyridines and use thereof as tyrosine kinase inhibitors |
US20160222014A1 (en) * | 2013-09-10 | 2016-08-04 | Asana Biosciences, Llc | Compounds for regulating fak and/or src pathways |
KR20190135464A (en) * | 2016-12-01 | 2019-12-06 | 압토스 바이오사이언시스 인코포레이티드 | Fused pyrimidines as BRD4 and JAK2 dual inhibitors and methods of use thereof |
CN110467615A (en) * | 2018-05-10 | 2019-11-19 | 四川科伦博泰生物医药股份有限公司 | Azolopyrimidines include its pharmaceutical composition and its preparation method and application |
CN111718348A (en) * | 2019-03-22 | 2020-09-29 | 首药控股(北京)有限公司 | WEE1 inhibitor, and preparation and application thereof |
-
2019
- 2019-10-15 GB GB201914910A patent/GB201914910D0/en not_active Ceased
-
2020
- 2020-10-14 WO PCT/EP2020/078960 patent/WO2021074251A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021074251A1 (en) | 2021-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276232A (en) | Pharmaceutical compounds | |
GB201911928D0 (en) | Pharmaceutical compounds | |
GB201800072D0 (en) | Pharmaceutical | |
GB201810245D0 (en) | Pharmaceutical compounds | |
GB201911944D0 (en) | Pharmaceutical compounds | |
GB201810239D0 (en) | Pharmaceutical compounds | |
GB201914910D0 (en) | Pharmaceutical compounds | |
GB202020191D0 (en) | Pharmaceutical compounds | |
GB201819961D0 (en) | Pharmaceutical compounds | |
GB201911517D0 (en) | Pharmaceutical composition | |
IL291570A (en) | Pharmaceutical compounds | |
GB201819960D0 (en) | Pharmaceutical compounds | |
GB201801562D0 (en) | Pharmaceutical compounds | |
GB201800378D0 (en) | Pharmaceutical compounds | |
GB202010409D0 (en) | Pharmaceutical compounds | |
GB201816369D0 (en) | Pharmaceutical compounds | |
GB201915932D0 (en) | Pharmaceutical compounds | |
GB201915273D0 (en) | Pharmaceutical compounds | |
GB202010408D0 (en) | Pharmaceutical compounds | |
SG11202110315SA (en) | Pharmaceutical composition | |
FI3908321T3 (en) | Pharmaceutical composition | |
GB201901989D0 (en) | Pharmaceutical combinations | |
GB201914267D0 (en) | Pharmaceutical compounds | |
GB201912067D0 (en) | Pharmaceutical compounds | |
GB201911311D0 (en) | Pharmaceutical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |